Bu F, Ye G, Morsheimer K, Mendoza A, Turner-Hubbard H, Herbst M
PLoS Pathog. 2024; 20(12):e1012817.
PMID: 39715280
PMC: 11723632.
DOI: 10.1371/journal.ppat.1012817.
Marzi A, Feldmann H
NPJ Vaccines. 2024; 9(1):186.
PMID: 39394249
PMC: 11470150.
DOI: 10.1038/s41541-024-00985-y.
Kainulainen M, Harmon J, Karaaslan E, Kyondo J, Whitesell A, Twongyeirwe S
J Med Virol. 2024; 96(10):e29946.
PMID: 39370872
PMC: 11874798.
DOI: 10.1002/jmv.29946.
Kandathil A, Blair P, Lu J, Anantharam R, Kobba K, Robinson M
PLoS Negl Trop Dis. 2024; 18(9):e0012451.
PMID: 39298515
PMC: 11460704.
DOI: 10.1371/journal.pntd.0012451.
Munyeku-Bazitama Y, Edidi-Atani F, Takada A
Viruses. 2024; 16(8).
PMID: 39205153
PMC: 11359311.
DOI: 10.3390/v16081179.
A broadly-neutralizing antibody against glycoprotein that potentiates the breadth and neutralization potency of other antibodies.
Donnellan F, Rayaprolu V, Rijal P, ODowd V, Parvate A, Callaway H
bioRxiv. 2024; .
PMID: 38979279
PMC: 11230233.
DOI: 10.1101/2024.06.21.600001.
Production and Purification of Filovirus Glycoproteins.
Noonan-Shueh M, Aman M, Kailasan S
Methods Mol Biol. 2024; 2762:17-25.
PMID: 38315357
DOI: 10.1007/978-1-0716-3666-4_2.
Development of an Immunochromatography Assay to Detect Marburg Virus and Ravn Virus.
Changula K, Kajihara M, Muramatsu S, Hiraoka K, Yamaguchi T, Yago Y
Viruses. 2023; 15(12).
PMID: 38140590
PMC: 10747695.
DOI: 10.3390/v15122349.
Ebola virus disease in children: epidemiology, pathogenesis, management, and prevention.
Dobbs K, Lobb A, Dent A
Pediatr Res. 2023; 95(2):488-495.
PMID: 37903937
DOI: 10.1038/s41390-023-02873-y.
Blocking of ebolavirus spread through intercellular connections by an MPER-specific antibody depends on BST2/tetherin.
Santos R, Ilinykh P, Pietzsch C, Ronk A, Huang K, Kuzmina N
Cell Rep. 2023; 42(10):113254.
PMID: 37858466
PMC: 10664807.
DOI: 10.1016/j.celrep.2023.113254.
Filoviruses: Scientific Gaps and Prototype Pathogen Recommendation.
Dupuy L, Spiropoulou C, Towner J, Spengler J, Sullivan N, Montgomery J
J Infect Dis. 2023; 228(Suppl 6):S446-S459.
PMID: 37849404
PMC: 11009505.
DOI: 10.1093/infdis/jiad362.
A Single-Dose Intranasal Combination Panebolavirus Vaccine.
Malherbe D, Kimble J, Atyeo C, Fischinger S, Meyer M, Cody S
J Infect Dis. 2023; 228(Suppl 7):S648-S659.
PMID: 37469133
PMC: 10651208.
DOI: 10.1093/infdis/jiad266.
A Highly Attenuated Panfilovirus VesiculoVax Vaccine Rapidly Protects Nonhuman Primates Against Marburg Virus and 3 Species of Ebola Virus.
Woolsey C, Borisevich V, Agans K, OToole R, Fenton K, Harrison M
J Infect Dis. 2023; 228(Suppl 7):S660-S670.
PMID: 37171813
PMC: 11009496.
DOI: 10.1093/infdis/jiad157.
Diagnostics of Ebola virus.
Bettini A, Lapa D, Garbuglia A
Front Public Health. 2023; 11:1123024.
PMID: 36908455
PMC: 9995846.
DOI: 10.3389/fpubh.2023.1123024.
Epidemiology of Ebolaviruses from an Etiological Perspective.
Jain S, Khaiboullina S, Martynova E, Morzunov S, Baranwal M
Pathogens. 2023; 12(2).
PMID: 36839520
PMC: 9963726.
DOI: 10.3390/pathogens12020248.
Estimating Risk of Introduction of Ebola Virus Disease from the Democratic Republic of Congo to Tanzania: A Qualitative Assessment.
Rugarabamu S, George J, Mbanzulu K, Mwanyika G, Misinzo G, Mboera L
Epidemiologia (Basel). 2022; 3(1):68-80.
PMID: 36417268
PMC: 9620938.
DOI: 10.3390/epidemiologia3010007.
Establishing a Public Health Emergency Operations Center in an Outbreak-Prone Country: Lessons Learned in Uganda, January 2014 to December 2021.
Kayiwa J, Homsy J, Nelson L, Ocom F, Kasule J, Wetaka M
Health Secur. 2022; 20(5):394-407.
PMID: 35984936
PMC: 10985018.
DOI: 10.1089/hs.2022.0048.
Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region.
Schoeder C, Gilchuk P, Sangha A, Ledwitch K, Malherbe D, Zhang X
PLoS Pathog. 2022; 18(5):e1010518.
PMID: 35584193
PMC: 9170092.
DOI: 10.1371/journal.ppat.1010518.
Pan-ebolavirus serology study of healthcare workers in the Mbandaka Health Region, Democratic Republic of the Congo.
Shaffer K, Hui S, Bratcher A, King L, Mutombe R, Kavira N
PLoS Negl Trop Dis. 2022; 16(3):e0010167.
PMID: 35255093
PMC: 8929691.
DOI: 10.1371/journal.pntd.0010167.
First laboratory confirmation and sequencing of Zaire ebolavirus in Uganda following two independent introductions of cases from the 10th Ebola Outbreak in the Democratic Republic of the Congo, June 2019.
Nyakarahuka L, Mulei S, Whitmer S, Jackson K, Tumusiime A, Schuh A
PLoS Negl Trop Dis. 2022; 16(2):e0010205.
PMID: 35192613
PMC: 8896669.
DOI: 10.1371/journal.pntd.0010205.